Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Véronique Raimond
Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Critical Evaluation of the Efficacy of New Drugs
Postgraduate Medical Journal
Medicine
Pcn355 - Utility in French Health-Economic Opinions: Key Learnings of a Retrospective Analysis in Oncology Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Potential Effects of Introducing Behind the Counter Drugs
Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology
JAMA - Journal of the American Medical Association
Medicine
Pss9 - Drugs Utilisation in the Italian Setting: The Case of Wamd, Dme and Rvo
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ethics Codes and Use of New and Innovative Drugs
British Journal of Clinical Pharmacology
Pharmacology